Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VIR · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
57
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Vir Biotechnology, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
VIR insider buying and selling by quarter
VIR insider selling · VIR insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · VIR ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
VIR executive sell shares · VIR board member insider trading · VIR insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | Napolitano Janet Director | Sale | 3,200 | $30K | Form 4 |
| May 27, 2026 | Sigal Charles Elliott Director | Award | 8,000 | — | Form 4 |
| May 27, 2026 | Napolitano Janet Director | Award | 8,000 | — | Form 4 |
| May 27, 2026 | MORE ROBERT J Director | Award | 8,000 | — | Form 4 |
| May 27, 2026 | Hatfield Jeffrey S. Director | Award | 8,000 | — | Form 4 |
| May 27, 2026 | Farid Ramy Director | Award | 8,000 | — | Form 4 |
| May 27, 2026 | BISCHOFBERGER NORBERT W Director | Award | 8,000 | — | Form 4 |
| May 1, 2026 | SATO VICKI L Director | Sale | 22,000 | $221K | Form 4 |
| Apr 29, 2026 | De Backer Marianne President and CEO · Director | Other | 233,532 | — | Form 4 |
| Apr 29, 2026 | De Backer Marianne President and CEO · Director | Other | 233,532 | — | Form 4 |
| Apr 6, 2026 | De Backer Marianne President and CEO · Director | Sale | 72,559 | $664K | Form 4 |
| Apr 1, 2026 | SATO VICKI L Director | Sale | 22,000 | $200K | Form 4 |
| Mar 2, 2026 | SATO VICKI L Director | Sale | 21,800 | $207K | Form 4 |
| Mar 2, 2026 | SATO VICKI L Director | Sale | 200 | $2K | Form 4 |
| Feb 24, 2026 | SATO VICKI L Director | Option | 42,377 | $63K | Form 4 |
| Feb 24, 2026 | SATO VICKI L Director | Sale | 42,177 | $411K | Form 4 |
| Feb 24, 2026 | SATO VICKI L Director | Sale | 200 | $2K | Form 4 |
| Feb 24, 2026 | Eisner Mark EVP and Chief Medical Officer | Sale | 1,616 | $15K | Form 4 |
| Feb 25, 2026 | Eisner Mark EVP and Chief Medical Officer | Sale | 1,889 | $19K | Form 4 |
| Feb 24, 2026 | De Backer Marianne CEO · Director | Sale | 14,762 | $141K | Form 4 |
| Feb 22, 2026 | Eisner Mark EVP and Chief Medical Officer | Award | 55,000 | — | Form 4 |
| Feb 23, 2026 | Eisner Mark EVP and Chief Medical Officer | Sale | 2,089 | $16K | Form 4 |
| Feb 22, 2026 | De Backer Marianne CEO · Director | Award | 285,000 | — | Form 4 |
| Feb 23, 2026 | De Backer Marianne CEO · Director | Sale | 19,039 | $142K | Form 4 |
| Feb 2, 2026 | SATO VICKI L Director | Sale | 22,000 | $170K | Form 4 |
De Backer Marianne
President and CEO · Director
Date
Apr 29
Shares
233,532
Price
—
Value
—
De Backer Marianne
President and CEO · Director
Date
Apr 29
Shares
233,532
Price
—
Value
—
De Backer Marianne
President and CEO · Director
Date
Apr 6
Shares
72,559
Price
$9.16
Value
$664K
Eisner Mark
EVP and Chief Medical Officer
Date
Feb 24
Shares
1,616
Price
$9.53
Value
$15K
Eisner Mark
EVP and Chief Medical Officer
Date
Feb 25
Shares
1,889
Price
$9.82
Value
$19K
De Backer Marianne
CEO · Director
Date
Feb 24
Shares
14,762
Price
$9.53
Value
$141K
Eisner Mark
EVP and Chief Medical Officer
Date
Feb 22
Shares
55,000
Price
—
Value
—
Eisner Mark
EVP and Chief Medical Officer
Date
Feb 23
Shares
2,089
Price
$7.45
Value
$16K
De Backer Marianne
CEO · Director
Date
Feb 23
Shares
19,039
Price
$7.45
Value
$142K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VIR insider trading
VIR insider trades
Vir Biotechnology, Inc. (VIR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including SVF Endurance (Cayman) Ltd (10 percent owner), SATO VICKI L (Director), De Backer Marianne (President and CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. VIR insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Vir Biotechnology, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VIR insider trading · 5 questionsThe insiders of Vir Biotechnology, Inc. (VIR) include executives and directors such as SVF Endurance (Cayman) Ltd (10 percent owner), SATO VICKI L (Director), De Backer Marianne (President and CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026